“…Studies with a high number of patients having metastasis or advanced-stage disease will show higher sensitivity rates for the studied diagnostic techniques. For example, in studies with a relatively high number of cases with clinically or histologi cally positive nodes, higher sensitivity rates for CT were obtained, up to 91 % (6,12,15), whereas in studies with more cases with negative nodes, sensitivity rates for CT were lower (eg, 60%) (4). The only study, to our knowledge, in which the results of US with US-guided FNAB, CT, and MR imaging were com pared in the same study population showed superior results of US wi th USguided FNAB (13).…”